Marino Brunori

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Massimo Offidani, Laura Corvatta, Monica Marconi et al. · PubMed · 2006 · 78 citations

Immunology, Pathology, Pharmacotherapy +16

Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells

Attilio Olivieri, Laura Corvatta, Mauro Montanari et al. · Bone Marrow Transplantation · 1998 · 70 citations

Heart Failure, Blood Progenitor Cells, Paroxysmal Atrial Fibrillation +6

Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA

Attilio Olivieri, Guido Gini, Caterina Bocci et al. · The Oncologist · 2012 · 62 citations · Full text

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study

Massimo Offidani, Laura Corvatta, Laura Maracci et al. · Blood Cancer Journal · 2013 · 61 citations · Full text

Hematological Malignancy, Oncology, Health Sciences +14

Amifostine can reduce mucosal damage after high‐dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study

Debora Capelli, Gino Santini, Cármino Antônio De Souza et al. · British Journal of Haematology · 2000 · 58 citations